Literature DB >> 9093800

Interleukin-1, -6, and -8 levels in juvenile chronic arthritis.

S Ozen1, U Saatci, A Bakkaloglu, O Ozdemir, N Besbas, S Kirazli, S Ozdemir.   

Abstract

The immunoinflammatory pathogenesis of juvenile chronic arthritis (JCA) involves the activation of many pathways including various cytokines. We have evaluated the levels of interleukin(IL)-1, IL-6 and IL-8 in 29 JCA patients. The age range was 1-16 with a mean of 10.1. A disease activity score was developed on the basis of: 1. constitutional symptoms and/or morning stiffness, 2. presence of joint swelling, 3.warmth, 4.limited range of motion, and 5.joint pain. This score correlated very significantly with laboratory disease activity markers such as erythrocyte sedimentation rate (ESR) and CRP (both p = 0.006) and also correlated with IL-1 and IL-6 levels. The levels of IL-1 decreased in four of the five patients with improved disease activity. IL-6 but not IL-1 correlated significantly with the number of inflamed joints (p = 0.013); IL-6 also strongly correlated with rheumatoid factor supporting this cytokine's role in B cell induction (p = 0). Haemoglobin values correlated negatively with the activity index, ESR, CRP, IL-1 and IL-6. IL-8 did not correlate with disease activity markers. In the systemic patients all cytokines tended to be higher. Our data suggest that interleukins 1 and 6 are effective in the pathogenesis of JCA. Whether cytokines may be used for monitoring therapy may be clarified with further studies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9093800     DOI: 10.1007/bf02247847

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  11 in total

1.  A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis.

Authors:  J T Cassidy; J E Levinson; J C Bass; J Baum; E J Brewer; C W Fink; V Hanson; J C Jacobs; A T Masi; J G Schaller
Journal:  Arthritis Rheum       Date:  1986-02

2.  Cytokines in childhood rheumatic diseases.

Authors:  P Woo
Journal:  Arch Dis Child       Date:  1993-11       Impact factor: 3.791

3.  Interleukin 6 and autoantibodies in juvenile rheumatoid arthritis.

Authors:  K Oen; G Danell
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

4.  Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis.

Authors:  F de Benedetti; M Massa; P Robbioni; A Ravelli; G R Burgio; A Martini
Journal:  Arthritis Rheum       Date:  1991-09

5.  Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

Authors:  A M Nouri; G S Panayi; S M Goodman
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

6.  Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis.

Authors:  F De Benedetti; P Robbioni; M Massa; S Viola; S Albani; A Martini
Journal:  Clin Exp Rheumatol       Date:  1992 Sep-Oct       Impact factor: 4.473

7.  Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias.

Authors:  J C Schooley; B Kullgren; A C Allison
Journal:  Br J Haematol       Date:  1987-09       Impact factor: 6.998

Review 8.  Cytokines and oncogenes in cellular interactions of rheumatoid arthritis.

Authors:  G M Keyszer; A H Heer; S Gay
Journal:  Stem Cells       Date:  1994-01       Impact factor: 6.277

9.  Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.

Authors:  R N Lipnick; P P Sfikakis; G L Klipple; G C Tsokos
Journal:  Clin Immunol Immunopathol       Date:  1993-07

10.  Inflammatory cytokine responses in juvenile chronic arthritis.

Authors:  M Rooney; J David; J Symons; F Di Giovine; H Varsani; P Woo
Journal:  Br J Rheumatol       Date:  1995-05
View more
  3 in total

1.  Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study.

Authors:  Wilco de Jager; Esther P A H Hoppenreijs; Nico M Wulffraat; Lucy R Wedderburn; Wietse Kuis; Berent J Prakken
Journal:  Ann Rheum Dis       Date:  2006-12-14       Impact factor: 19.103

2.  The impact of disease activity and tumour necrosis factor-α inhibitor therapy on cytokine levels in juvenile idiopathic arthritis.

Authors:  H M Walters; N Pan; T J A Lehman; A Adams; G D Kalliolias; Y S Zhu; F Santiago; J Nguyen; L Sitaras; S Cunningham-Rundles; T J Walsh; S S Toussi
Journal:  Clin Exp Immunol       Date:  2016-04-13       Impact factor: 4.330

3.  Elevated serum levels of soluble CD154 in children with juvenile idiopathic arthritis.

Authors:  Sampath Prahalad; Thomas B Martins; Anne E Tebo; April Whiting; Bronte Clifford; Andrew S Zeft; Bernadette McNally; John F Bohnsack; Harry R Hill
Journal:  Pediatr Rheumatol Online J       Date:  2008-05-28       Impact factor: 3.054

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.